New Network To Boost Coordination On Innovative Drugs Across Europe
The newly established EU Innovation Network aims to increase the visibility of the support being offered by national competent authorities to innovative medicinal products in member states, and help boost the delivery of novel medicines to patients.
You may also be interested in...
Regulators involved in the EU Innovation Network are working on a pilot aimed at sponsors, who want to have an early dialogue on product development issues with a national competent authority in Europe, but also want to get other NCAs or innovation offices involved.
European Medicines Agency chief Guido Rasi, will replace the UK's Ian Hudson as chair of the International Coalition of Medicines Regulatory Authorities in October.
A new EU group is keeping a bird's eye view on new innovative medicinal products being brought before member states’ innovation offices, and has flagged up "emerging challenges" and "interesting cases" identified throughout 2017 that need further discussion at the level of the EU medicines network.